RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial

Conditions

• Gastroesophageal Adenocarcinoma

Interventions

• DRUG: FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel)
• DRUG: Simvastatin
• DRUG: Durvalumab

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre